Why Is Silexion Therapeutics Stock Trading Higher On Thursday?

benzinga.com/news/health-care/25/07/46771995/why-is-silexion-therapeutics-stock-trading-higher-on-thursday

Silexion Therapeutics Corp. (NASDAQ:SLXN) released new preclinical data on Thursday, revealing inhibition rates of up to 97% in pancreatic cancer cells and almost 90% in colorectal cancer cells.
These findings include the company's first evidence of efficacy against the clinically…

This story appeared on benzinga.com, 2025-07-31 19:14:14.
The Entire Business World on a Single Page. Free to Use →